Cargando…

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure

OBJECTIVE: In chronic kidney disease (CKD), both anemia and deregulated phosphate metabolism are common and predictive of adverse outcome. Previous studies suggest that iron status influences phosphate metabolism by modulating proteolytic cleavage of FGF23 into C-terminal fragments. Red cell distrib...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Breda, Fenna, Emans, Mireille E., van der Putten, Karien, Braam, Branko, van Ittersum, Frans J., Kraaijenhagen, Rob J., de Borst, Martin H., Vervloet, Marc, Gaillard, Carlo A. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469605/ https://www.ncbi.nlm.nih.gov/pubmed/26079688 http://dx.doi.org/10.1371/journal.pone.0128994

Ejemplares similares

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging
por: Emans, Mireille E, et al.
Publicado: (2012)

Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
por: Jie, Kim E, et al.
Publicado: (2010)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
por: Humalda, Jelmer K., et al.
Publicado: (2016)

Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study
por: Leenders, Nicoline H. J., et al.
Publicado: (2018)

Validity and reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS(®)) using computerized adaptive testing in patients with advanced chronic kidney disease
por: van der Willik, Esmee M, et al.
Publicado: (2022)

Responsiveness and minimal important change of seven PROMIS computerized adaptive tests (CAT) in patients with advanced chronic kidney disease
por: Terwee, Caroline B., et al.
Publicado: (2023)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Fibroblast growth factor 23: are we ready to use it in clinical practice?
por: Bouma-de Krijger, Annet, et al.
Publicado: (2020)

Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations
por: Adema, Aaltje Y., et al.
Publicado: (2016)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Short-Term Erythropoietin Treatment Does Not Substantially Modulate Monocyte Transcriptomes of Patients with Combined Heart and Renal Failure
por: Jie, Kim E., et al.
Publicado: (2012)

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
por: van der Vaart, Amarens, et al.
Publicado: (2023)

Unraveling the Kinetics of the 10–23 RNA-Cleaving DNAzyme
por: Montserrat Pagès, Aida, et al.
Publicado: (2023)

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort
por: Vervloet, Marc G, et al.
Publicado: (2012)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes
por: Verkaik, Melissa, et al.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
por: Sikorra, Stefan, et al.
Publicado: (2020)

A computational approach to identify efficient RNA cleaving 10–23 DNAzymes
por: Pine, Angela C, et al.
Publicado: (2023)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

Shedding Light on the Complex Regulation of FGF23
por: Vervloet, Marc G.
Publicado: (2022)

Physical performance in patients treated with nocturnal hemodialysis - a systematic review of the evidence
por: Dam, Manouk, et al.
Publicado: (2019)

Cleaving and migrating
por: Wells, William A.
Publicado: (2001)

Complete Hypokalemic Quadriparesis as a First Presentation of Sjögren Syndrome
por: An, Jason, et al.
Publicado: (2018)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Z$^{0}$ mass and width and the number of neutrinos
por: VanDalen, G J
Publicado: (1994)

Members of the Fibroblast Growth Factor Receptor Superfamily Are Proteolytically Cleaved by Two Differently Activated Metalloproteases
por: Dixit, Garima, et al.
Publicado: (2021)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023)

Preemptive dosage reduction of nadroparin in patients with renal failure: a retrospective case series
por: Russcher, Marije, et al.
Publicado: (2013)

In vitro selection of small RNA-cleaving deoxyribozymes that cleave pyrimidine–pyrimidine junctions
por: Schlosser, Kenny, et al.
Publicado: (2008)

Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13
por: Djamiatun, Kis, et al.
Publicado: (2012)

Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients
por: Bech, Anneke P., et al.
Publicado: (2015)

Trilogía Cleave : Eclipse ; Imposturas ; Antigua luz /
por: Banville, John
Publicado: (2018)

Nocturnal Hemodialysis Leads to Improvement in Physical Performance in Comparison with Conventional Hemodialysis
por: Dam, Manouk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_voi7bjf0lrcgn2nsrl8masb2ia